{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T04:06:57Z","timestamp":1749874017383,"version":"3.41.0"},"reference-count":38,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"3","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:p>Background: Thrombosis and coronary artery disease (CAD) are complex disorders influenced by genetic factors. Specific gene variations, such as Factor V (FV) G1691A (Leiden), FV H1299R, and Prothrombin (FII) G20210A, have been implicated in thrombotic events and CAD. However, their precise role in CAD development remains controversial. This study investigated the prevalence and association of these gene variations with thrombosis and CAD in the Turkish population. Methods: A case-control study included 406 healthy individuals and 64 CAD patients. Genotyping for FV G1691A, FV H1299R, and FII G20210A was performed using a strip assay. Fisher's exact test compared allele and genotype frequencies between the CAD and control groups. Results: No significant differences were observed in genotype frequencies of FV G1691A, FV H1299R, and FII G20210A between the CAD and control groups (p&gt;0.05). Similarly, allele frequencies did not differ significantly between the two groups (p&gt;0.05). Conclusions: The findings suggest that FV G1691A, FV H1299R, and FII G20210A variations may not play a significant role in the development of CAD in the Turkish population studied. These results are consistent with the existing conflicting literature on the association between these gene variations and CAD. Further research with larger sample sizes and diverse populations is warranted to elucidate the role of these variations in CAD pathogenesis.<\/jats:p>","DOI":"10.5937\/jomb0-39668","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T08:53:56Z","timestamp":1740387236000},"page":"447-452","source":"Crossref","is-referenced-by-count":0,"title":["Association of FV G1691A, FV H1299R, and FII G20210A variations with thrombosis and coronary artery disease (CAD): A population-based study"],"prefix":"10.5937","volume":"44","author":[{"suffix":"Sevda","given":"\u00d6zmen","family":"\u00dcnall\u0131","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye\u015fim","family":"\u00d6zarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aylin","family":"K\u00f6seler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramazan","family":"Sab\u0131rl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Sucu","given":"Derya","family":"Kaynak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Ko\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. Sergi C, Al Jishi T , Walker M. Factor V Leiden mutation in women with early recurrent pregnancy loss: a meta-analysis and systematic review of the causal association. Arch Gynecol Obstet 2015 Mar; 291(3): 671-9;","DOI":"10.1007\/s00404-014-3443-x"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Van Cott EM, Khor B, Zehnder JL. Factor V Leiden. Am J Hematol 2016 Jan; 91(1): 46-9;","DOI":"10.1002\/ajh.24222"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Kottke-Marchant K. Genetic polymorphisms associated with venous and arterial thrombosis: an overview. Arch Pathol Lab Med 2002; 126: 295-304;","DOI":"10.5858\/2002-126-0295-GPAWVA"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, et al. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: The Linz Peripheral Arterial Disease (LIPAD) Study J Vasc Surg 2005; 41: 808-15;","DOI":"10.1016\/j.jvs.2005.01.039"},{"key":"ref5","unstructured":"5. Kujovich J. Prothrombin-Related Thrombophilia. 2006 Jul 25 [Updated 2021 Feb 4]. In: Adam MP , Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022. Available at: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1148;"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Lunghi B, Lacoviello L, Gemmati D, Dilasio MG, Castoldi E, Pinotti M, et al. Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb. Haemost 1996; 75: 45-8;","DOI":"10.1055\/s-0038-1650219"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Castoldi E, Rosing J, Girelli D, Hoekema L, Lunghi B, Mingozzi F , et al. Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma. Thromb Haemost 2000; 83: 362-5;","DOI":"10.1055\/s-0037-1613821"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Zaatari G.S, Otrock Z.K, Sabbagh A.S, Mahfouz R.A. Prevalence of factor V R2 (H1299R) polymorphism in the Lebanese population. Pathology 2006; 38: 442-4;","DOI":"10.1080\/00313020600922934"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Kuhli-Hattenbach C, Hellstern P , N\u00e4gler DK, Kohnen T , Hattenbach LO, et al. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G\/5G and the risk of retinal vein occlusion. Ophthalmic Genet 2017 Sep-Oct; 38(5): 413-7;","DOI":"10.1080\/13816810.2016.1244694"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Bernardi F , Faioni E.M, Castoldi E, Lunghi B, Castaman G, Sacchi E, et al. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 1997; 90: 1552-7;","DOI":"10.1182\/blood.V90.4.1552"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. de Visser MCH, Guasch JF, Kamphuisen PW, Vos HL, Rosendaal FR, Bertina RM. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis. Thromb Haemost 2000; 83: 577-82;","DOI":"10.1055\/s-0037-1613866"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Aleksova A, Di Nucci M, Gobbo M, Pradella P , Salam K, Barbati G, et al. Factor-V HR2 haplotype and thromboembolic disease. Acta Cardiol 2015 Dec; 70(6): 707-11;","DOI":"10.1080\/AC.70.6.3120184"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Castoldi E, Simioni P , Kalafatis M, B Lunghi B, D T ormene D, Girelli D, et al. Combinations of 4 mutations (FV R506Q, FV H1299R, FVY1702C, PT 20210G\/A) affecting the prothrombinase complex in a thrombophilic family. Blood 2000; 96: 1443-8;","DOI":"10.1182\/blood.V96.4.1443.h8001443_1443_1448"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Dziadosz M, Baxi L.V . Global prevalence of prothrombin gene mutation G20210A and implications in women's health: a systematic review. Blood Coagul Fibrinolysis 2016; 27: 481-4;","DOI":"10.1097\/MBC.0000000000000562"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703;","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Simioni P , Tormene D, Manfrin D, Gavasso S, Luni S, Stocco D, et al. Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. Br J Haematol 1998; 103: 1045-450;","DOI":"10.1046\/j.1365-2141.1998.01112.x"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Sabbagh AS, Ibrahim G, Kanan Z, Shammaa DMR, Khalek RA, Ghasham M, et al. Prevalence of the prothrombin G20210A polymorphism in the Lebanese population: use of a reverse hybridization strip assay approach. Mol Biol Rep 2007; 36: 399-403;","DOI":"10.1007\/s11033-007-9193-0"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL et al. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997; 90: 1747-450;","DOI":"10.1182\/blood.V90.5.1747"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Shemesh A1, Hoffman R, Nadir Y, Keren-Politansky A, Monreal M, Brenner B, et al. Clinical significance of prothrombin G20210A mutation in homozygous patients. Am J Hematol 2017 Oct; 92(10): E618-E620;","DOI":"10.1002\/ajh.24859"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Leroyer C, Mercier B, Oger E, Chenu E, Abgrall JF , F\u00e9rec C, et al. Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients. Thromb Haemost 1998; 80: 49-51;","DOI":"10.1055\/s-0037-1615137"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. Yilmaz S, Bayan K, T\u00fcz\u00fcn Y, Batun S, A Alt\u0131nta A. A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey. J Thromb Thrombolysis 2006 Dec; 22(3): 205-12;","DOI":"10.1007\/s11239-006-9032-5"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4;","DOI":"10.1016\/S0140-6736(95)91803-5"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"23. Lucotte G, Mercier G. Population genetics of factor V Leiden in Europe. Blood Cells Mol Dis 2001; 27: 362-7;","DOI":"10.1006\/bcmd.2001.0388"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"24. Dajani R, Fatahallah R, Dajani A, Al-Shboul M, Khader Y , et al. Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan. Mol Biol Rep 2012; 39: 9133-8;","DOI":"10.1007\/s11033-012-1785-7"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"25. Agaoglu N, T\u00fcrkyilmaz S, Ovali E, U\u00e7ar F , Agaoglu C. Prevalence of prothrombotic abnormalities in patients with acute mesenteric ischemia. World J Surg 2005; 29: 1135-8;","DOI":"10.1007\/s00268-005-7692-5"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"26. Akar N, Akar E, Dalgin G, S\u00f6z\u00fc\u00f6z A, \u00d6m\u00fcrl\u00fc K, Cin S. Frequency of Factor V (1691 G --> A) mutation in Turkish population. Thromb Haemost 1997; 78: 1527-8;","DOI":"10.1055\/s-0038-1665446"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"27. Atasay B, Arsan S, G\u00fcnlemez A, Kemahli S, Akar N. Factor V Leiden and prothrombin gene 20210A variant in neonatal thromboembolism and in healthy neonates and adults: a study in a single center. Pediatr Hematol Oncol 2003; 20: 627-634;","DOI":"10.1080\/08880010390243059"},{"key":"ref28","unstructured":"28. Eroglu Z, Biray Avci C, Kilic M, Kosova B, \u00d6zen E, G\u00fcnd\u00fcz C, et al. The prevalence of Factor V Leiden gene variant analysis of donor and recipient at the organ transplantation. Cent. Ege Univ. Ege Tip Dergisi 2006; 45: 185-9;"},{"key":"ref29","unstructured":"29. G\u00fcrgey A, Mesci L. The prevalence of factor V Leiden (1691 G-->A) mutation in Turkey. Turk J Pediatr 1997; 39: 313-5;"},{"key":"ref30","unstructured":"30. Ozbek U, Tang\u00fcn Y. Frequency of factor V Leiden in Turkey. Int J Hematol 1996; 164: 291-2;"},{"key":"ref31","unstructured":"31. Ulukus M, Eroglu Z, Yeniel AO, Toprak E, Kosova B, Turan \u00d6, et al. Frequency of Factor V Leiden (Gc1691G>A), prothrombin (G20210A) and methylenetetrahydrofolate reductase (C677T) genes variants in women with adverse pregnancy outcome. J. Turkish-German Gynecol Assoc 2006; 7: 195-201;"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"32. Russo C, Girelli D, Olivieri O, Guarini P, Manzato F, Pizzolo F, et al. G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease. Circulation 2001; 103: 2436-40;","DOI":"10.1161\/01.CIR.103.20.2436"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. Ridker PM, Hennekens CH, Miletich JP . G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 1999; 99: 999-1004;","DOI":"10.1161\/01.CIR.99.8.999"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"34. Croft SA, Daly ME, Steeds RP , KS Channer KS, Samani NJ, Hampton KK, et al. The prothrombin 20210A allele and its association with myocardial infarction. Thromb Haemost 1999; 81: 861-4;","DOI":"10.1055\/s-0037-1614588"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"35. Ardissino D, Mannucci PM, Merlini PA, Duca F , Fetiveau R, T agliabue L, et al. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 1999; 94: 46-51;","DOI":"10.1182\/blood.V94.1.46.413a27_46_51"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"36. Redondo M, Watzke HH, Stucki B, Sulzer I, Biasiutti FD, Binder BR, et al. Coagulation factors II, V, and X, prothrombin gene 20210 G-.A transition, and factor V Leiden in coronary artery disease. High clotting activity is an independent risk factor for myocardial infarction. Arterioscl Thromb Vasc Biol 1999; 19: 1020-5;","DOI":"10.1161\/01.ATV.19.4.1020"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"37. Burzotta F , Paciaroni K, De Stefano V , Crea F , Maseri A, Leone G, et al. Prothrombin gene polymorphism and coronary ischaemic syndromes: a phenotype-specific meta-analysis of 12 034 subjects Heart 2004; 90: 82-6;","DOI":"10.1136\/heart.90.1.82"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"38. Ercan B, T amer L, Sucu N, Pekdemir H, \u00c7amsar\u0131 A, Atik U. Factor VLeiden and Prothrombin G20210A Gene Polymorphisms in Patients with Coronary Artery Disease. Yonsei Med J 2008; 49: 237-43;","DOI":"10.3349\/ymj.2008.49.2.237"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Asocijacija varijacija FV G1691A, FV H1299R i FII G20210A sa trombozom i bolestima koronarnih arterija (CAD) - studija na populacionom nivou"],"language":"en","link":[{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2025\/1452-82582503447Q.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T16:49:56Z","timestamp":1749833396000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582503447Q"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-39668","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"type":"print","value":"1452-8258"},{"type":"electronic","value":"1452-8266"}],"subject":[],"published":{"date-parts":[[2025]]}}}